Results 61 to 70 of about 53,966 (218)
Ocular Manifestations of Metabolic Syndrome: A Systemic Vascular Phenotype
Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9809-9818, November 2026.ABSTRACT Context Metabolic syndrome (MetS) is defined by central obesity, insulin resistance, hypertension and dyslipidemia. MetS affects over one‐third of US adults. Beyond its cardiovascular burden, MetS has clinically relevant associations with ocular health and may contribute to a systemic vascular and neuro‐metabolic phenotype involving the retina,
Ron T. Varghese, Ansu A. John
wiley +1 more source
Intravitreal Bevacizumab for Traumatic Choroidal Rupture
Optometry and Vision Science, 2015 ABSTRACT Purpose To report a case of visual loss associated with traumatic choroidal rupture after blunt ocular trauma that was successfully treated with an early intravitreal bevacizumab injection despite the absence of choroidal neovascularization (CNV).
Min, Kim +4 more
openaire +3 more sources
The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
, 2014 Objectives: To evaluate the short-term intraocular pressure (IOP) changes after intravitreal injection of 0.05 mL (1.25 mg) bevacizumab. Materials and Methods: The study included 57 eyes of 57 patients who had an intravitreal injection of 0.05 mL ...
Pelin Yılmazbaş +3 more
core +1 more source
BMC Pediatrics, 2019 Background Incontinentia Pigmenti is a rare disease affecting multiple organs. Fifty of patients show affection of the eye with retinopathy and possible amaurosis being the worst outcome.
S. Kunzmann +6 more
doaj +1 more source
From Molecular Targets to Advanced Delivery Systems: Aptamers for Precision Ocular Therapeutics
Advanced Therapeutics, Volume 9, Issue 10, October 2026.Aptamer‐based strategies are revolutionizing ocular disease management through highly specific molecular recognition of disease specific molecular targets. This review systematically integrates therapeutic aptamer sequences, diagnostic aptasensor platforms, and targeted delivery strategies, highlighting design principles, ocular bioavailability ...
Minal Thacker +4 more
wiley +1 more source
Acta Ophthalmologica, 2021 PurposeTo compare the visual and anatomical outcomes of intravitreal bevacizumab combined with the dexamethasone intravitreal implant and bevacizumab monotherapy in eyes with diabetic macular edemaMethodsWe retrospectively reviewed 41 eyes of 41 patients with diabetic macular edema who underwent either intravitreal bevacizumab (1.25 mg) (20 eyes, IVB ...
Yeseul Gong, Kuidong Kang
openaire +1 more source
Clinical Ophthalmology, 2012 Masaaki Saito,1 Tomohiro Iida,1,2 Mariko Kano,1 Kanako Itagaki11Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, 2Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo ...
Saito M, Iida T, Kano M, Itagaki K
doaj
Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye
Journal of Current Ophthalmology, 2019 Purpose: To evaluate the effects of anti-vascular endothelial growth factors (anti-VEGF) on the vessels of the non-treated eyes following intravitreal injections.
Mohammadreza Peyman +4 more
doaj +1 more source
Trials, 2008 Background The management of neovascular age-related macular degeneration (nAMD) has been transformed by the introduction of agents delivered by intravitreal injection which block the action of vascular endothelial growth factor-A (anti-VEGF agents). One
Bunce Catey +2 more
doaj +1 more source
International Journal of Retina and Vitreous, 2022 Background To investigate the adjunctive effect of an intravitreal ROCK inhibitor (fasudil) in combination with intravitreal bevacizumab (IVB) on refractory macular edema secondary to retinal vein occlusion (RVO).
Sahba Fekri +6 more
doaj +1 more source